Botox maker Allergan draws bid from Valeant (Update)
Valeant Pharmaceuticals is teaming up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion.
Apr 21, 2014
Valeant Pharmaceuticals is teaming up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion.
Apr 21, 2014
(Medical Xpress)—A small gene that is embedded in a larger, well-known gene is the true leukemia-promoting force usually attributed to the larger gene, according to a new study by researchers at The Ohio State University ...
Apr 21, 2014
A telephone-based collaborative care model helped manage depression and anxiety, and improved health-related quality of life in patients with heart disease.
Apr 21, 2014
A third of Medicare beneficiaries assigned to accountable care organizations (ACOs) in 2010 or 2011 were not assigned to the same ACO in both years and much of the specialty care received was provided outside the patients' ...
Apr 21, 2014
For the first time, researchers have demonstrated that narrowing of the carotid artery in the neck without any symptoms may be linked to problems in learning, memory, thinking and decision-making, compared to people with ...
Apr 21, 2014